TLM 2022 Recorded Sessions
View a selection of recorded TLM 2022 sessions.
AASLD webinars are short, innovative sessions where participants can ask the experts questions about hot topics within their respective fields.
Continuing Education Activities
Earn CME, CE, or MOC while viewing presentation videos from AASLD specialty meetings, The Post Graduate Course and the Transplant Hepatology Board Review.
Fundamentals of Liver Disease
Alcohol-associated Liver Disease enduring material is now available. Crediting claiming for this enduring material is available from February 21, 2022 through February 20, 2025. …
Here are some new courses that might interest you!
- Product not yet rated Contains 1 Component(s)
This webinar is part one of a two-part series which features a hepatologist and a surgeon who helped to build and expand their center's living donor liver transplant programs. Attendees of this webinar will gain a greater understanding of how to build and sustain a high-volume living donor liver transplant program from the perspective of a hepatologist and a transplant surgeon who each helped to grow their respective living donor programs.
2023 Webinar: Optimizing the Liver Clinic’s Role in Managing Alcohol Use Disorder (AUD) Among Patients with Alcohol-Associated Liver Disease (ALD)
Globally, alcohol-associated liver disease (ALD) accounts for 50% of liver-related deaths and is the leading indication for liver transplantation (Lee BP et al JAMA Med 2020). Abstinence from alcohol is the strongest predictor of long-term survival in ALD. While evidence-based therapies for AUD exist to increase rates of abstinence and reduce rates of heavy drinking, patients with ALD rarely receive these therapies (Rogal S et al Hepatology 2020). The barriers to accessing AUD therapy among patients with ALD are likely multifactorial. While the hepatology clinic represents a potential opportunity to provide therapy for AUD to improve clinical outcomes, this is rarely done. A recent survey (Im GY et al CGH 2020) commissioned by the AASLD ALD Special Interest Group reported that the majority (71%) hepatology providers never provide behavioral or pharmacotherapy for AUD, with the most common reason being low comfort (84%). Most (77%) reported low addiction education and 90% desired more training. We have developed this webinar proposal to address these clinical gaps by educating our hepatology community and empowering them with the tools to deliver evidence-based interventions for AUD among patients with ALD in their liver clinic. In this AASLD webinar, we provide a very clinically-applicable overview of steps that providers (hepatologists, nurse practitioners, etc.) in a liver clinic can make to address AUD for their patients with ALD. The webinar provides a multi-disciplinary approach, but focuses on what is realistic and practical for an every-day liver clinic, which can have variable resources and patient populations.
- Contains 1 Component(s)
Our understanding of “immune tolerance” in chronic hepatitis B has been evolving, with continued debates on their clinical management and treatment. This webinar will help provide updates in broad perspective, scientific context and clinical implications.
- Product not yet rated Contains 2 Component(s)
Webinar hosted by the Women's Initiatives Committee on Tuesday, December 13, 2022.
- Contains 2 Component(s)
Webinar hosted by the Hypertension SIG on Monday, December 12, 2022.
|Access Date||Quiz Result||Score||Actions|
AASLD members have complimentary access to LiverLearning® . Not an AASLD member and would like to join? Visit the AASLD website to sign up today!
If you would like access to LiverLearning® content as a non-member, please contact AASLD at email@example.com.